A451 Superiority of VTD over TD Incorporated Into ASCT for Newly Diagnosed MM

Autor: Massimo Offidani, Paola Tacchetti, Michele Cavo, Vittorio Montefusco, Maria Concetta Petti, Filippo Gherlinzoni, V. De Stefano, Elena Zamagni, Nicola Cascavilla, Franco Narni, Monica Galli, Luigi Gugliotta, MC Pallotti, Norbert Pescosta, Francesca Patriarca, Lucia Pantani, Tommaso Caravita, Michele Baccarani, M.T. Petrucci, Patrizia Tosi, Emanuele Angelucci, Stelvio Ballanti, Antonio Ledda, Giorgio Rossi, Tonino Spadano, R Zambello, Maria Goldaniga, Alessandro Petrucci, S Bringhen, Vincenzo Callea, Annamaria Brioli, Chiara Nozzoli, Giulia Perrone, Michela Ceccolini, F. Di Raimondo

Publikováno v: Clinical Lymphoma and Myeloma. 9:S73

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::eca1b6e602204ad9c9acd7ab6ac37b85
https://doi.org/10.1016/s1557-9190(11)70590-x

Baseline thrombophilic alterations and risk of venous thromboembolism in 266 multiple myeloma patients primarily treated with thalidomide and high-dose dexamethasone

Autor: Lelia Valdrè, Michela Ceccolini, Antonio Ledda, Affra Carubelli, Claudia Cellini, Michele Cavo, Annamaria Brioli, MC Pallotti, Giulia Perrone, Cristina Legnani, Lucio Catalano, Elisa Favaretto, Paola Tacchetti, Sadia Falcioni, Francesco Casulli, Alessandro Gozzetti, Francesca Patriarca, Michele Baccarani, Elena Zamagni, Luciano Masini, Catello Califano, Patrizia Tosi, Lucia Pantani, Gualtiero Palareti, Michela Cini, Silvestro Volpe

Publikováno v: ResearcherID

Venous thromboembolism (VTE) has emerged as a major adverse event of primary induction therapy with thalidomide (thal) and dexamethasone (dex) for newly diagnosed multiple myeloma (MM). Aim of the present study was to investigate the relationship bet

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0f48eb698cae8ebc697c0b84eaf9256
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000251101100253&KeyUID=WOS:000251101100253

Radiotherapy at the End of Life: From Retrospective Analysis to Strategies to Improve Outcomes.

Autor: Rossi R; Palliative Care Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy (R.R., P.C., M.C.P., V.V.)., Cravero P; Palliative Care Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy (R.R., P.C., M.C.P., V.V.). Electronic address: paola.cravero@irst.emr.it., Pallotti MC; Palliative Care Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy (R.R., P.C., M.C.P., V.V.)., Valenti V; Palliative Care Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy (R.R., P.C., M.C.P., V.V.)., Massa I; Outcome research, Healthcare Administration, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy (I.M.)., Foca F; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy (F.F., O.N.)., Nanni O; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy (F.F., O.N.)., Pieri M; Radiotherapy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy (M.P., A.R., L.T.)., Romeo A; Radiotherapy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy (M.P., A.R., L.T.)., Tontini L; Radiotherapy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy (M.P., A.R., L.T.)., Donati CM; Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy (C.M.D., A.G.M.)., Morganti AG; Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy (C.M.D., A.G.M.); Radiation Oncology, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy (A.G.M.)., Maltoni M; Medical Oncology Unit, Department of Specialized, Experimental and Diagnostic Medicine (DIMES), University of Bologna, Bologna, Italy (M.M.).

Publikováno v: Journal of pain and symptom management [J Pain Symptom Manage] 2024 Jun; Vol. 67 (6), pp. e927-e929. Date of Electronic Publication: 2024 Mar 10.

Identification of palliative care needs and prognostic factors of survival in tailoring appropriate interventions in advanced oncological, renal and pulmonary diseases: a prospective observational protocol.

Autor: Valenti V; Palliative Care Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Rossi R; Palliative Care Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy romina.rossi@irst.emr.it., Scarpi E; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Dall'Agata M; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Bassi I; Respiratory and Critical Care Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Clinical Integrated and Experimental Medicine (DIMES), University of Bologna, Bologna, Italy., Cravero P; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., La Manna G; Nephrology, Dialysis and Transplantation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Magnoni G; Nephrology, Dialysis and Transplantation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Marchello M; Respiratory and Critical Care Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Clinical Integrated and Experimental Medicine (DIMES), University of Bologna, Bologna, Italy., Mosconi G; Nephrology and Dialysis Unit, 'Morgagni-Pierantoni' Hospital, Forli, Italy., Nanni O; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Nava S; Respiratory and Critical Care Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Clinical Integrated and Experimental Medicine (DIMES), University of Bologna, Bologna, Italy., Pallotti MC; Palliative Care Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Rapposelli IG; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Ricci M; Palliative Care Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Scrivo A; Nephrology, Dialysis and Transplantation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Spazzoli A; Nephrology and Dialysis Unit, 'Morgagni-Pierantoni' Hospital, Forli, Italy., Valenti D; Unità Operativa Complessa Rete delle Cure Palliative, AUSL di Bologna, Bologna, Italy., Zambianchi L; Nephrology and Dialysis Unit, 'Morgagni-Pierantoni' Hospital, Forli, Italy., Caraceni A; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Maltoni M; Palliative Care Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Department of Clinical Integrated and Experimental Medicine (DIMES), University of Bologna, Bologna, Italy.

Publikováno v: BMJ open [BMJ Open] 2023 May 30; Vol. 13 (5), pp. e065971. Date of Electronic Publication: 2023 May 30.

Prognostication in palliative radiotherapy-ProPaRT: Accuracy of prognostic scores.

Autor: Maltoni M; Medical Oncology Unit, Department of Specialized, Experimental and Diagnostic Medicine (DIMES), University of Bologna, Bologna, Italy., Scarpi E; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Dall'Agata M; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Micheletti S; Radiotherapy Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Pallotti MC; Palliative Care Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Pieri M; Radiotherapy Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Ricci M; Palliative Care Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Romeo A; Radiotherapy Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Tenti MV; Palliative Care Unit, Azienda Unità Sanitaria Locale (AUSL) Romagna, Forlì, Italy., Tontini L; Radiotherapy Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Rossi R; Palliative Care Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.

Publikováno v: Frontiers in oncology [Front Oncol] 2022 Aug 16; Vol. 12, pp. 918414. Date of Electronic Publication: 2022 Aug 16 (Print Publication: 2022).